PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tsinghua University School of Medicine, Beijing, China.\', \'Department of Cardiology, Peking Union Medical College Hospital, Beijing, China.\', \'Beijing University of Chinese Medicine, Beijing, China.\', \'Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.\', \'Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.\', \'Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.\', \'Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa1592
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33079200
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all